Articles

Severe refractory asthma: current treatment options and ongoing research

Francesco Menzella MD, Francesca Bertolini MSc, PhD, Mirella Biava MSc, Carla Galeone MSc, Chiara Scelfo MD, Marco Caminati MD

Article Type

Review

Published

In this review, the different biological options available for the treatment of severe refractory asthma, their mechanism of action, and the overlapping aspects of their usage in clinical practice are discussed.

Read more

Dismissing the fallacies of childhood eczema management: case scenarios and an overview of best practices

Kam Lun Hon MBBS, MD (CUHK), FAAP, FCCM, Kin Fon Leong MBBS, MRCPCH, Theresa Leung MBBS, FRCPCH, FHKAM(Paed), FHKCPaed, Alexander KC Leung MBBS, FRCPC, FRCP(UK & Irel), FRCPCH, FAAP

Article Type

Review

Published

AD is often complicated and difficult to manage in many Asian cities and effective therapy is impeded by fallacies. In this article eleven anonymized case scenarios are described to illustrate issues associated with these fallacies. A literature review is performed and possible solutions to handle or dismiss these fallacies are discussed.

Read more

Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries

Daniela Opris-Belinski MD, PhD, Shandor F Erdes MD, PhD, Simeon Grazio MD, PhD, Ladislav Šenolt MD, PhD, Maja Hojnik MD, PhD, Orsolya Nagy MD, PhD, Diana Marina BSc, Sándor Szántó MD, PhD, DSc

Article Type

Original Research

Published

This study assessed the impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis in five Central and Eastern Europe countries.

Read more

The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition

Muhammad Saad MD, Umut Gomceli MD, Pranav Ravi MD, Andrisael G Lacoste MD, Neil Shah MD, Timothy J Vittorio MD

Article Type

Review

Published

In the recent era, SGLT-2 inhibitors have shown success in decreasing cardiovascular mortality in the type 2 diabetes mellitus population. This article will help the reviewer to comprehend the pathophysiology of heart failure and the potential role of SGLT-2 inhibitors in the management algorithm of heart failure and its associated risk factors in type 2 diabetes mellitus.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.